FDA Drug Application (202012) for EPROSARTAN MESYLATE by MYLAN PHARMS INC

Back to FDA Applications sponsored by MYLAN PHARMS INC

Application Number202012
Product Number001
FormTABLET;ORAL
DosageEQ 400MG BASE
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameEPROSARTAN MESYLATE
Active IngredientEPROSARTAN MESYLATE



Back to FDA Applications sponsored by MYLAN PHARMS INC

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.